Register entry
- Registered sites
- 0
- Active NDC listings
- 14
- Live patents
- 18
- Countries
- 0
Catalogue
Drug listings by form and route
1414 active NDC listings: 14 human prescription drug. By marketing category: NDA 7, ANDA 6, BLA 1.
| Dosage form | NDCs |
|---|---|
| capsule | 4 |
| granule | 4 |
| solution | 3 |
| injection | 1 |
| powder, for solution | 1 |
| tablet, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 13 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| eton pharmaceuticals, inc. | 14 |
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8338489 | HEMANGEOLpropranolol hydrochloride | use | Oct 2028 |
| 8987262 | HEMANGEOLpropranolol hydrochloride | use | Oct 2028 |
| 9717740 | ALKINDI SPRINKLEhydrocortisone | use | Nov 2032 |
| 9675559 | ALKINDI SPRINKLEhydrocortisone | use | Jan 2033 |
| 9649280 | ALKINDI SPRINKLEhydrocortisone | product | May 2034 |
| 11904046 | KHINDIVIhydrocortisone | product | Feb 2043 |
| 12133914 | KHINDIVIhydrocortisone | use | Feb 2043 |
| 12214010 | DESMODAdesmopressin acetate | product | Apr 2044 |
| 12343372 | DESMODAdesmopressin acetate | product | Apr 2044 |
Catalogue
Marketed products
14| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Alkindi Sprinkle | Hydrocortisone | granule, oral | 71863-109NDA |
| Alkindi Sprinkle | Hydrocortisone | granule, oral | 71863-110NDA |
| Alkindi Sprinkle | Hydrocortisone | granule, oral | 71863-111NDA |
| Alkindi Sprinkle | Hydrocortisone | granule, oral | 71863-112NDA |
| Betaine Anhydrous | Betaine Anhydrous | powder, for solution, oral | 71863-115ANDA |
| Carglumic Acid | Carglumic Acid | tablet, for suspension, oral | 71863-114ANDA |
| DESMODA | Desmopressin Acetate Oral Solution | solution, oral | 71863-123NDA |
| HEMANGEOL | Propranolol Hydrochloride | solution, oral | 71863-132NDA |
| Increlex | Mecasermin | injection, subcutaneous | 71863-216BLA |
| Khindivi | Hydrocortisone | solution, oral | 71863-116NDA |
| Nitisinone | Nitisinone | capsule, oral | 71863-119ANDA |
| Nitisinone | Nitisinone | capsule, oral | 71863-120ANDA |
| Nitisinone | Nitisinone | capsule, oral | 71863-121ANDA |
| Nitisinone | Nitisinone | capsule, oral | 71863-122ANDA |
Compare
Other companies listing hydrocortisone
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- Reckitt Benckiser LLC7 sites · 174 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Strides Pharma Science Limited5 sites · 230 NDC
- L'Oreal USA Products Inc5 sites · 213 NDC
- Encube Ethicals Limited5 sites · 77 NDC
Enquiry
Common questions
- Is Eton Pharmaceuticals, Inc. FDA approved?
- Eton Pharmaceuticals, Inc. holds no registered establishment of its own; 14 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Eton Pharmaceuticals, Inc. make?
- 14 products are listed under Eton Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as capsule; granule; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.